CCG 0933--MERCAPTOPURINE FOLLOWED BY CYTOSINE ARABINOSIDE IN CHILDREN

CCG 0933--儿童中先用巯基嘌呤，然后用阿糖胞苷

• 批准号: 6278089
• 负责人: BEVERLY LANGE
• 金额: $ 2.4万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6278089
• 关键词: clinical research; cytosine arabinoside; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer remission /regression; outcomes research; pediatric neoplasm /cancer; pediatric pharmacology; thiopurine

This is a multicenter phase I-II trial supported by the NIH through the Children's Cancer Group Phase I grant. Four children have been treated at The Children's Hospital of Philadelphia: two have had complete responses and two have had a mixed or MTD has not been reached.

这是一项多中心的I-II期试验，由NIH通过 儿童癌症组织第一阶段赠款。四名儿童在医院接受了治疗 费城儿童医院：两家已有完全反应 有两个人患有混合疾病或MTD尚未达到。